Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models.

Lung cancer remains the leading cause of cancer deaths in the United States and the rest of the world. The advent of molecularly directed therapies holds promise for improvement in therapeutic efficacy. Cytosolic phospholipase A2 (cPLA2) is associated with tumor progression and radioresistance in mo...

Full description

Bibliographic Details
Main Authors: Dinesh Thotala, Jeffrey M Craft, Daniel J Ferraro, Rama P Kotipatruni, Sandeep R Bhave, Jerry J Jaboin, Dennis E Hallahan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3716600?pdf=render